PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
24.26%
Net income growth under 50% of AVGO's 74.90%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
-2.07%
Negative yoy D&A while AVGO is 1.73%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-111.86%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
-26.32%
Negative yoy SBC while AVGO is 10.61%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
4400.00%
Slight usage while AVGO is negative at -103.60%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-28.95%
Both yoy AR lines negative, with AVGO at -151.56%. Martin Whitman would suspect an overall sector lean approach or softer demand.
195.77%
Some inventory rise while AVGO is negative at -81.04%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
-76.92%
Negative yoy AP while AVGO is 204.70%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
155.26%
Some yoy usage while AVGO is negative at -120.42%. John Neff would see competitor possibly generating more free cash from minor accounts than we do.
-72.00%
Negative yoy while AVGO is 301.92%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
32.18%
Operating cash flow growth at 50-75% of AVGO's 54.82%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
12.03%
Some CapEx rise while AVGO is negative at -46.84%. John Neff would see competitor possibly building capacity while we hold back expansions.
-12.03%
Negative yoy acquisition while AVGO stands at 106.09%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
1.51%
Less growth in investment purchases vs. AVGO's 101.72%, preserving near-term liquidity. David Dodd would confirm no strategic investment opportunities are lost.
-57.44%
We reduce yoy sales while AVGO is 78.13%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
7.89%
Less 'other investing' outflow yoy vs. AVGO's 28.57%. David Dodd would see a stronger short-term cash position unless competitor invests more wisely.
-1027.69%
We reduce yoy invests while AVGO stands at 104.17%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
100.00%
Debt repayment 1.25-1.5x AVGO's 79.28%. Bruce Berkowitz would see an edge in lowering interest burdens unless competitor invests in profitable expansions.
-20.21%
Both yoy lines negative, with AVGO at -64.49%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
5.12%
Buyback growth of 5.12% while AVGO is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.